FDA Label for Oasis Tears Lubricant Eye

View Indications, Usage & Precautions

Oasis Tears Lubricant Eye Product Label

The following document was submitted to the FDA by the labeler of this product Oasis Medical, Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Other



Drug Facts


Active Ingredients



Glycerin (0.22%)


Purpose



lubricant Eye Drops


Uses



  • For the temporary relief of burning and irritation due to dryness of the eye
  • For the temporary relief of discomfort due to minor irritations of the eye or to exposure to wind or sun
  • For use as a protectant against further irritation or to relieve dryness of the eye

Warnings



For external use only


Do Not Use



  • If solution changes color or becomes cloudy
  • If you are sensitive to any ingredient in this product

When Using This Product



  • To avoid contamination do not touch tip of container to any surface
  • Replace cap after using

Stop Use And Ask A Doctor If



You experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours


Otc - Keep Out Of Reach Of Children



Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.


Directions



Instill 1 or 2 drops in the affected eye(s) as needed.


Otc - Questions



Questions, or to report an adverse event call:

(800) 631-7180 or (909) 305-5400 or log onto www.oasistears.com


Other Information



  • Protect from light and freezing
  • Store at or below 77°F/25°C

Inactive Ingredients



EDTA, potassium sorbate, sodium chloride, sodium hyaluronate, sodium hydroxide, sodium phosphate dibasic, sodium phosphate monobasic, water


* Please review the disclaimer below.